FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105976273> ?p ?o ?g. }

• W2105976273 abstract "The immune system plays an important role in the multifactorial biologic system during the development of neoplasias. However, the involvement of the inflammatory response in the promotion/control of malignant cells is still controversial, and the cell subsets and the mechanisms involved are poorly investigated. The goal of this study was to characterize the clinical-pathological status and the immunophenotyping profile of tumor infiltrating lymphocytes and their association with the animal survival rates in canine mammary carcinomas.Fifty-one animals with mammary carcinomas, classified as carcinomas in mixed tumors-MC-BMT = 31 and carcinomas-MC = 20 were submitted to systematic clinical-pathological analysis (tumor size; presence of lymph node and pulmonary metastasis; clinical stage; histological grade; inflammatory distribution and intensity as well as the lymphocytic infiltrate intensity) and survival rates. Twenty-four animals (MC-BMT = 16 and MC = 8) were elected to the immunophenotypic study performed by flow cytometry.Data analysis demonstrated that clinical stage II-IV and histological grade was I more frequent in MC-BMT as compared to MC. Univariate analysis demonstrated that the intensity of inflammation (moderate/intense) and the proportion of CD4+ (> or = 66.7%) or CD8+ T-cells (<33.3%) were not associated with worse survival rate. Multivariate analysis demonstrated that only lymphocytic infiltrate intensity > or = 600 (P = 0.02) remained as independent prognostic factor. Despite the clinical manifestation, the lymphocytes represented the predominant cell type in the tumor infiltrate. The percentage of T-cells was higher in animals with MC-BMT without metastasis, while the percentage of B-lymphocytes was greater in animals with metastasized MC-BMT (P < 0.05). The relative percentage of CD4+ T-cells was significantly greater in metastasized tumors (both MC-BMT and MC), (P < 0.05) while the proportion of CD8+ T-cells was higher in MC-BMT without metastasis. Consequently, the CD4+/CD8+ ratio was significantly increased in both groups with metastasis. Regardless of the tumor type, the animals with high proportions of CD4+ and low CD8+ T-cells had decreased survival rates.The intensity of lymphocytic infiltrate and probably the relative abundance of the CD4+ and CD8+ T-lymphocytes may represent important survival prognostic biomarkers for canine mammary carcinomas." @default.
• W2105976273 created "2016-06-24" @default.
• W2105976273 creator A5012052830 @default.
• W2105976273 creator A5017523406 @default.
• W2105976273 creator A5021459076 @default.
• W2105976273 creator A5022976564 @default.
• W2105976273 creator A5027035909 @default.
• W2105976273 creator A5044925516 @default.
• W2105976273 creator A5049220207 @default.
• W2105976273 creator A5074774495 @default.
• W2105976273 creator A5077556893 @default.
• W2105976273 date "2010-06-04" @default.
• W2105976273 modified "2023-10-14" @default.
• W2105976273 title "Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates" @default.
• W2105976273 cites W1573335082 @default.
• W2105976273 cites W1655698060 @default.
• W2105976273 cites W1967060514 @default.
• W2105976273 cites W1972998033 @default.
• W2105976273 cites W1973855239 @default.
• W2105976273 cites W1983946189 @default.
• W2105976273 cites W2001798961 @default.
• W2105976273 cites W2010871781 @default.
• W2105976273 cites W2016493554 @default.
• W2105976273 cites W2019125765 @default.
• W2105976273 cites W2022403851 @default.
• W2105976273 cites W2025309264 @default.
• W2105976273 cites W2025480239 @default.
• W2105976273 cites W2031576122 @default.
• W2105976273 cites W2033978532 @default.
• W2105976273 cites W2053029785 @default.
• W2105976273 cites W2053430617 @default.
• W2105976273 cites W2057796145 @default.
• W2105976273 cites W2058260090 @default.
• W2105976273 cites W2064551230 @default.
• W2105976273 cites W2073266148 @default.
• W2105976273 cites W2085761004 @default.
• W2105976273 cites W2109017823 @default.
• W2105976273 cites W2121935432 @default.
• W2105976273 cites W2123105952 @default.
• W2105976273 cites W2125699401 @default.
• W2105976273 cites W2126882378 @default.
• W2105976273 cites W2129226890 @default.
• W2105976273 cites W2138733343 @default.
• W2105976273 cites W2142027100 @default.
• W2105976273 cites W2145178265 @default.
• W2105976273 cites W2150300421 @default.
• W2105976273 cites W2157058802 @default.
• W2105976273 cites W4243139957 @default.
• W2105976273 cites W66577011 @default.
• W2105976273 doi "https://doi.org/10.1186/1471-2407-10-256" @default.
• W2105976273 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2894795" @default.
• W2105976273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20525350" @default.
• W2105976273 hasPublicationYear "2010" @default.
• W2105976273 type Work @default.
• W2105976273 sameAs 2105976273 @default.
• W2105976273 citedByCount "81" @default.
• W2105976273 countsByYear W21059762732012 @default.
• W2105976273 countsByYear W21059762732013 @default.
• W2105976273 countsByYear W21059762732014 @default.
• W2105976273 countsByYear W21059762732015 @default.
• W2105976273 countsByYear W21059762732016 @default.
• W2105976273 countsByYear W21059762732017 @default.
• W2105976273 countsByYear W21059762732018 @default.
• W2105976273 countsByYear W21059762732019 @default.
• W2105976273 countsByYear W21059762732020 @default.
• W2105976273 countsByYear W21059762732021 @default.
• W2105976273 countsByYear W21059762732022 @default.
• W2105976273 countsByYear W21059762732023 @default.
• W2105976273 crossrefType "journal-article" @default.
• W2105976273 hasAuthorship W2105976273A5012052830 @default.
• W2105976273 hasAuthorship W2105976273A5017523406 @default.
• W2105976273 hasAuthorship W2105976273A5021459076 @default.
• W2105976273 hasAuthorship W2105976273A5022976564 @default.
• W2105976273 hasAuthorship W2105976273A5027035909 @default.
• W2105976273 hasAuthorship W2105976273A5044925516 @default.
• W2105976273 hasAuthorship W2105976273A5049220207 @default.
• W2105976273 hasAuthorship W2105976273A5074774495 @default.
• W2105976273 hasAuthorship W2105976273A5077556893 @default.
• W2105976273 hasBestOaLocation W21059762731 @default.
• W2105976273 hasConcept C121608353 @default.
• W2105976273 hasConcept C126322002 @default.
• W2105976273 hasConcept C142724271 @default.
• W2105976273 hasConcept C143998085 @default.
• W2105976273 hasConcept C144301174 @default.
• W2105976273 hasConcept C146357865 @default.
• W2105976273 hasConcept C151730666 @default.
• W2105976273 hasConcept C167672396 @default.
• W2105976273 hasConcept C196166836 @default.
• W2105976273 hasConcept C203014093 @default.
• W2105976273 hasConcept C207886595 @default.
• W2105976273 hasConcept C2777802486 @default.
• W2105976273 hasConcept C2778001805 @default.
• W2105976273 hasConcept C2779013556 @default.
• W2105976273 hasConcept C2780140570 @default.
• W2105976273 hasConcept C2780849966 @default.
• W2105976273 hasConcept C38180746 @default.
• W2105976273 hasConcept C530470458 @default.
• W2105976273 hasConcept C553184892 @default.
• W2105976273 hasConcept C71924100 @default.
• W2105976273 hasConcept C86803240 @default.

• next